BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bashash M, Shah A, Hislop G, Brooks-Wilson A, Le N, Bajdik C. Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. Can J Gastroenterol 2008;22:143-8. [PMID: 18299732 DOI: 10.1155/2008/645107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Verlato G, Di Leo A, Rossi GM, de Manzoni G. Epidemiology of Gastric Cancer and Screening Programs. In: de Manzoni G, Roviello F, Siquini W, editors. Surgery in the Multimodal Management of Gastric Cancer. Milano: Springer Milan; 2012. pp. 1-7. [DOI: 10.1007/978-88-470-2318-5_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Bashash M, Shah A, Hislop G, Treml M, Bretherick K, Janoo-Gilani R, Leach S, Le N, Bajdik C, Brooks-Wilson A. Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction. PLoS One. 2013;8:e59157. [PMID: 23527119 DOI: 10.1371/journal.pone.0059157] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
3 Xie F, O'Reilly D, Ferrusi IL, Blackhouse G, Bowen JM, Tarride JE, Goeree R. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. J Am Coll Radiol. 2009;6:317-323. [PMID: 19394572 DOI: 10.1016/j.jacr.2009.01.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
4 Veisani Y, Delpisheh A, Sayehmiri K, Rahimi E. Demographic and histological predictors of survival in patients with gastric and esophageal carcinoma. Iran Red Crescent Med J 2013;15:547-53. [PMID: 24396572 DOI: 10.5812/ircmj.11847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Cattelan L, Ghazawi FM, Le M, Lagacé F, Savin E, Zubarev A, Gantchev J, Tomaszewski M, Sasseville D, Waschke K, Litvinov IV. Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study. Cancer Med 2020;9:401-17. [PMID: 31715645 DOI: 10.1002/cam4.2700] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zargar A, Miroliaee A, Ahmadi Gooraji S, Hajaghamohammadi A. Determination of Effective Factors on Survival of GI Cancers: Results of Five Years Follow up in Iranian Population. Glob J Health Sci 2015;8:256-66. [PMID: 26755479 DOI: 10.5539/gjhs.v8n6p256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Dassen AE, Dikken JL, Bosscha K, Wouters MW, Cats A, van de Velde CJ, Coebergh JW, Lemmens VE. Gastric cancer: decreasing incidence but stable survival in the Netherlands. Acta Oncol. 2014;53:138-142. [PMID: 23829603 DOI: 10.3109/0284186x.2013.789139] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
8 Ben-David K, Sarosi GA, Cendan JC, Howard D, Rossidis G, Hochwald SN. Decreasing morbidity and mortality in 100 consecutive minimally invasive esophagectomies. Surg Endosc. 2012;26:162-167. [PMID: 21792712 DOI: 10.1007/s00464-011-1846-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
9 Rajabi B, Corral JC, Hakim N, Mulla ZD. Descriptive epidemiology of gastric adenocarcinoma in the State of Texas by ethnicity: Hispanic versus White non-Hispanic. Gastric Cancer 2012;15:405-13. [DOI: 10.1007/s10120-011-0127-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tinmouth J, Green J, Ko YJ, Liu Y, Paszat L, Sutradhar R, Rabeneck L, Urbach D. A population-based analysis of esophageal and gastric cardia adenocarcinomas in Ontario, Canada: incidence, risk factors, and regional variation. J Gastrointest Surg 2011;15:782-90. [PMID: 21409602 DOI: 10.1007/s11605-011-1450-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
11 Otterstatter MC, Brierley JD, De P, Ellison LF, Macintyre M, Marrett LD, Semenciw R, Weir HK. Esophageal cancer in Canada: trends according to morphology and anatomical location. Can J Gastroenterol 2012;26:723-7. [PMID: 23061066 DOI: 10.1155/2012/649108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
12 Rodríguez-Camacho E, Pita-Fernández S, Pértega-Díaz S, López-Calviño B, Seoane-Pillado T. Clinical-pathological characteristics and prognosis of a cohort of oesophageal cancer patients: a competing risks survival analysis. J Epidemiol 2015;25:231-8. [PMID: 25716135 DOI: 10.2188/jea.JE20140118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
13 Huang Q, Sun Q, Fan XS, Zhou D, Zou XP. Recent advances in proximal gastric carcinoma. J Dig Dis. 2016;17:421-432. [PMID: 27129018 DOI: 10.1111/1751-2980.12355] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
14 Bashash M, Hislop TG, Shah AM, Le N, Brooks-Wilson A, Bajdik CD. The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada. BMC Cancer 2011;11:164. [PMID: 21554722 DOI: 10.1186/1471-2407-11-164] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
15 Bashash M, Yavari P, Hislop TG, Shah A, Sadjadi A, Babaei M, Le N, Brooks-Wilson A, Malekzadeh R, Bajdik C. Comparison of two diverse populations, British Columbia, Canada, and Ardabil, Iran, indicates several variables associated with gastric and esophageal cancer survival. J Gastrointest Cancer 2011;42:40-5. [PMID: 21103956 DOI: 10.1007/s12029-010-9228-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Yin C, Zhang J, Gao M, Shen Q, Liu D. Epidemiological investigation of Barrett's esophagus in patients with gastroesophageal reflux disease in Northwest China. Journal of Medical Colleges of PLA 2012;27:187-97. [DOI: 10.1016/s1000-1948(12)60019-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
17 Ishak NS, Abdul Rahman H, Lee SHF, Lu SK, Naing L. Incidence, Survival and Prognostic Factors of Oesophagogastric Cancer. J Gastrointest Cancer 2021. [PMID: 33392958 DOI: 10.1007/s12029-020-00559-w] [Reference Citation Analysis]
18 Shin A, Won YJ, Jung HK, Kong HJ, Jung KW, Oh CM, Choe S, Lee J. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database. J Gastroenterol Hepatol 2018;33:1961-8. [PMID: 29802647 DOI: 10.1111/jgh.14289] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
19 Cao J, Yang T, Wang G, Zhang H, You Y, Chen J, Yang J, Yang W. Analysis of the clinicopathological features and prognostic factors in 734 cases of Chinese Hui and Han patients with adenocarcinoma of the esophagogastric junction. Surg Oncol 2018;27:556-62. [PMID: 30217319 DOI: 10.1016/j.suronc.2018.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Merchant SJ, Kong W, Gyawali B, Hanna TP, Chung W, Nanji S, Patel SV, Booth CM. First-Line Palliative Chemotherapy for Esophageal and Gastric Cancer: Practice Patterns and Outcomes in the General Population. JCO Oncol Pract 2021;:OP2000397. [PMID: 33449833 DOI: 10.1200/OP.20.00397] [Reference Citation Analysis]